Stock Earnings

Question 1

Quels sont les états financiers clés de MoonLake Immunotherapeutics ?

Accepted Answer

Selon le dernier état financier (Form-10K), MoonLake Immunotherapeutics a un total d'actifs de $478, un bénéfice net loss de $-118

Question 2

Quels sont les ratios financiers clés pour MLTX ?

Accepted Answer

Le ratio de liquidité de MoonLake Immunotherapeutics est 15.41, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de MoonLake Immunotherapeutics sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently MoonLake Immunotherapeutics data is not available.

Question 4

MoonLake Immunotherapeutics est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, MoonLake Immunotherapeutics a un bénéfice net loss de $-118

Question 5

MoonLake Immunotherapeutics a-t-elle des passifs ?

Accepted Answer

yes, MoonLake Immunotherapeutics a un passif de 31

Question 6

Combien d'actions en circulation MoonLake Immunotherapeutics a-t-elle ?

Accepted Answer

MoonLake Immunotherapeutics a un total d'actions en circulation de 63

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--
Cost of Revenue	--	--	--	--	--
Gross Profit	--	--	--	--	--
Selling, General & Admin	38	30	22	23	18
Research & Development	162	112	31	42	35
Operating Expenses	200	143	54	65	53
Other Non Operating Income (Expenses)	24	22	10	0	0
Pretax Income	-178	-120	-43	-64	-53
Income Tax Expense	0	0	0	0	0
Net Income	-176	-118	-36	-49	-53
Net Income Growth	225.99%	227.99%	-27%	-8%	--
Shares Outstanding (Diluted)	63.28	62.87	49.12	29.36	36.93
Shares Change (YoY)	1%	28%	67%	-21%	--
EPS (Diluted)	-2.79	-1.89	-0.73	-1.7	-1.45
EPS Growth	221%	158%	-56.99%	17%	--
Free Cash Flow	-166	-117	-43	-55	-35
Free Cash Flow Per Share	-2.62	-1.86	-0.87	-1.87	-0.94
Gross Margin	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%
EBITDA	-198	-142	-54	-65	-53
EBITDA Margin	0%	0%	0%	0%	0%
D&A For EBITDA	2	1	0	0	0
EBIT	-200	-143	-54	-65	-53
EBIT Margin	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%

MoonLake Immunotherapeutics (MLTX) Price